Christian Soschner public
[search 0]

Download the App!

show episodes
 
Beginner's Mind with Christian Soschner is a show about breakthrough innovators, entrepreneurs, investors, thought leaders, and the stories behind their success. Christian Soschner invites the listeners to learn with him from the best and brightest minds behind disruptive businesses, innovative investments, prolific social movements, and technologies powering game-changing innovation. In intimate conversations, the host deconstructs the stories to help turn their wisdom into practical tactic ...
 
Loading …
show series
 
What are the opportunities for Biotechs in the Chinese Market? Get answers to this question in this podcast with the BFC Group. ⭐We are talking about The BFC Group The Capital Market Landscape in China Deal Structuring in China Clinical Strategies for China Why Affordability and Accessibility of new drugs matter in China ⭐About BFC Group: BFC Group…
 
Fundraising in Israel and the United States – In this episode, I have a conversation with Tuvik Beker, CEO of Pangea Biomed, who has started, developed, and exited companies in the United States and Israel. Now he is developing Pangea Biomed to start the next revolution in precision oncology. Tuvik Beker is a seasoned entrepreneur, an experienced e…
 
In this episode, Tobias Silberzahn, McKinsey talks about biohacking 101 – habits that make a difference, digital health eco-system, and much more… Tobias Silberzahn is a trained biochemist and immunologist and works as a Partner in McKinsey's Berlin office, where he is a member of the Healthcare and Innovation Practice. His work focuses on healthca…
 
What are decentralized clinical trials? What are the benefits of decentralized clinical trials? Why are decentralized clinical trials the way of the future? Emily Mitchell, Executive Director of ICON’s DCT team, discusses the benefits of these trials and what needs to be considered to ensure these benefits are realized. Emily Mitchell has over 15 y…
 
What is the best approach to starting a novel deep tech life science company? In this episode, I am talking with Samatha Dale Strasser, CSO, and co-founder of Pepper Bio, about her academic career at the University of Cambridge and MIT and the process of starting Pepper Bio. Backed by VC firm NFX, Pepper Bio uses proprietary lab methods and computa…
 
What is the best methodology for presenting your Company to investors, industry partners, and public funding organizations? Here is the answer: In this episode, Donna LaVoie presents her famous “15-slides-methodology” in great detail. Donna is a proven strategic communications leader in health and science innovation. She is a trusted advisor on str…
 
Happy Birthday, Inits. Today 20 years ago – July 27, 2002 – Inits – Vienna’s most important high Tech Incubation Program was created. In this episode, I am talking with Irene Fialka, CEO of Inits. In 20 years, Inits has supported over 300 high-tech #startups with the necessary tools for a successful and sustainable market entry. Dr. Irene Fialka is…
 
What is happening in all things digital assets, cryptocurrencies, NFTs, and alike? The market crashed. Is it all over now? Investing with experts is always the best idea when investing in new areas. This episode was recorded in February 2022, and I am happy that I had the chance to speak with two experts in digital assets from Austria: Astrid Wooll…
 
It is the 80th episode on my podcast channel. In 2020 I wanted to try how podcasts can bring value to my life science business community. One of the first speakers on the podcast was Alexander Belcredi, Phagomed. He and Co-CEO Lorenzo Corsini started their Company in 2015 and developed Alternatives to Antibiotics.; which was also the title of Episo…
 
These days many sources are highlighting the shocking scale of the global mental health crisis and how this affects approx—a staggering one billion people worldwide - over one-seventh of the global population. “Unfortunately, as harrowing and monstrous this number is”, the investor Christian Angermayer wrote in a blog post, “it is my belief this is…
 
Warren Buffett recommends buying companies with a great moat. Something that makes the company unique and protects the business from the competition. Patents are the best moats. Do you want to know why? Then listen to Gerda Redl. Who is the speaker? Dr. Gerda Redl is a patent attorney with more than 20 years of experience in the life sciences indus…
 
What is going on in the world of digital assets in 2022? In May 2010, 10,000 BTC bought 2 Pizza. Last year in November, the same amount had a value of 600 Million dollars. A lot has evolved since 2010 in the digital asset ecosystem. That's why I asked Alexander Valtingojer, CEO of Coinpanion, to discuss the latest development in the crypto market. …
 
How Did the Conference Industry Change in the last two years? Philadelphia in 2019 was the last Bio I attended in person. In March 2020, the world shut down to respond to the novel viral threat. Since then, all conferences have been digital. What effect did this have on the conference Industry – especially the Bio US? Listen to Rich Masters, Chief …
 
Are you interested to expand your business into Asian Markets? Then this episode might be for you. As Program Manager of the Global Incubator Network Austria (GIN), Lisa Stöger has successfully connected the Austrian startup ecosystem with the world's most innovative startup hubs for the last 4 years. With a focus on Asian markets, she supports Aus…
 
Do you want to know why networking and leadership are so important to be successful in business? And why everybody, including employees, needs to learn those skills? Then this episode is for you. Mark is the author of The Career Toolkit, Essential Skills for Success That No One Taught You. Educated at MIT, Mark has spent his career launching and fi…
 
Do you want to know how to value a company and what Julia Roberts has to do with it? Then listen to Bharat Kanodia in this episode number 73. Valuation is one of the most difficult exercises in the startup world. How can you put a price tag on a company that doesn’t exist yet? Get help from an expert: Bharat Kanodia has valued over 2000 businesses …
 
Do you want to reach out to Japanese companies and universities? Then you should know what makes Japan special and different to have a smooth business experience. Different Cultures – Different Rules and Different ways to success Japan is the second biggest market for pharmaceuticals globally. The area is not only interesting for its sales potentia…
 
Did you know that almost 90% of all product ideas fail in clinical trials? Surprising to me was that lack of efficacy doesn't seem to be the main reason why clinical trials fail in the first place. Other factors are at play, and most of them are manageable risks when the right team is at work. In this episode: Strategic considerations for setting u…
 
Big corporations strive to bring new solutions to their customers to help them solve their most pressing problems. To do so the corporation needs to be innovative. That's why companies like Apple, Google, Pfizer, and similar players want to cooperate with start-ups and scale-ups globally. Such cooperations strive to collaborate with top startups, i…
 
Lately, investors and researchers have published more and more information on longevity research and development. Investors like Sergey Young or Christian Angermayer started to bet significant capital on this topic. What is going on in this field on the research side? What are potential applications to increase the Lifespan? And when will those inn…
 
What significant problems does the food industry face today? Which solutions are already in development? In this episode, I am talking with Mauricio Agudelo and Lina María Toro about Sustainable Food Innovation in South America. BIALTEC assists animal protein producers to improve productivity and profitability through precision nutrition, understan…
 
Innovation needs collaboration on a global scale. Making things happen requires entrepreneurs who love science and work day and night to connect the best minds globally and support them to translate their science into products and businesses. In this episode, I have a conversation with Kai Lamottke, CEO and Co-Founder of Bicoll. Dr. Kai Lamottke is…
 
Part 7 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Formula 1 Fuels Hand Sanitization Open Source and Technology I hope you enjoy the conversati…
 
Part 6 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about NFTs Metaverse NanoMetaGames Austrian Entrepreneurship Week From Morning Moonshots to Future…
 
Part 5 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about The Effects of the Pandemic on Business Life The Future of ADCs in Oncology Mental Health Ps…
 
Part 4 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Biotech in Austria Culture of Success Business Angels, Investment and Market Perspective Cus…
 
Part 3 of the Year in Review Recording. 1 hour 15 minutes of exciting conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Content Marketing with a Podcast Life Science Industry in Austria Content Marketing and So…
 
Part 2 of the Year in Review Recording. 1 hour 15 minutes of exciting conversations with speakers from previous podcast episodes and business partners of the hosts. What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Health Literacy and the Healthcare System Venture Capital in 2021 Digitalization in Drug D…
 
This is Part 1 of the 7,5 hours conversations marathon before Christmas with speakers from previous podcast episodes and business partners of the host and co-host of the Podcast. In this episode, we talk about Covid19 Cryptocurrencies Cybersecurity and Merger & Acquisition I hope you enjoy the conversation the same way as I did. Who are the Experts…
 
In this episode, I am having a conversation with Sascha Berger, Partner at TVM Capital. Dr. Sascha Berger is a Partner at TVM Capital, based in Munich, Germany. TVM Capital is one of the pioneer transatlantic Life Science Venture Capital funds with Europe and North America teams. Sascha joined TVM Capital in 2016, helped raise the current $480M fun…
 
In this episode, I am having a conversation with Bettina Resl, Public Affairs Head Europe Consumer Healthcare at Sanofi. Bettina Resl joined Sanofi Austria in May 2017 as Country Head Public Affairs & Patient Advocacy. From April 2020 to June 2021 she was also responsible for corporate communications and finally took over the position of Public Aff…
 
In this episode, I have a conversation with Jaromir Zahradka and we will talk about early-stage investments in DeepTech Life Science companies. He has 5+ years of C-level experience and has been engaged in 8 Biotech spin-offs. He built a unique network within CE institutions and TTOs and has deep scientific and licensing market expertise with over …
 
In today’s episode, we explore Clinical Development with Ole Dammann, the owner of KFGN, a group of 6 clinical trial sites in Germany, and after joining Pratia, several sites in Eastern Europe. Ole Dammann is one of the best experts in clinical trial management in the LSG2G Community. Ole is currently working on the digitization of clinical researc…
 
In this conversation, I will talk with Peter Llewellyn-Davies, CEO of Apeiron and President of Biotech Austria about the Future of Life Science Entrepreneurship and Investment in Europe. Topics we discuss in the show: The Development of the Life Science Eco-System in Europe How Family Offices Support Life Science Companies in Europe How to Translat…
 
In this conversation, I will talk with Oliver Mavher and Michael Deichsel about Crypto Trading and taxes. Topics we discuss in the show: The questions that I consider relevant for everybody owning digital assets: What if someone gets paid in Bitcoin or other Cryptocurrencies? Is that a taxable event? What if someone invests in those novel digital a…
 
In this conversation, we will talk about the future of the Early-Stage Ecosystem in Europe. Speaker in the Episode: Alexander Schwartz joined IST cube in 2018 as a Partner. He has more than 15 years of experience in management consulting, eight of which with McKinsey & Company. Ingrid Kelly Spillman joined the IST Tech Transfer team in October 2018…
 
The industry gains complexity, and I am happy that a speaker from the LSG2G community has dedicated time to speak about the Future of the Food Industry. Speaker in the Episode: Dr. Caroline E. Heil Since Jul. 1, 2021, Caroline has been CEO of The New Meat Company AG, a young stock-listed, purpose-driven impact investment company in Berlin focusing …
 
Tech Transfer describes the process to bring scientific inventions from the discovery stage into companies for translational and clinical R&D. To gain more insights into this area, I invited a tech transfer expert from the LSG2G Community to this conversation. Speaker in this Episode is Saara Inkinen, Nordic Catalyst. Dr. Inkinen is a technology tr…
 
In this conversation, we discuss the development of the European Pharma Eco-System, different business models, and what it takes to lead a company to success. Today’s speaker is Dimitrios Tzalis. In the 90s, he received a Ph.D. from the University of California, San Diego, a Master of Science in Chemistry from the University of Chicago, and a Maste…
 
Here is my conversation with Andrea Sommer about the advantages of patents for private deep-tech companies. Timestamps: For those who want to listen to specific parts of the episode, here are the timestamps: 00:00 Opening Christian Soschner 02:00 Intro Andrea Sommer – Importance of Patents 03:48 The Role of Patents in Deep Tech Companies – Understa…
 
Here is my conversation with Kurt Höller and Joy Cürten from EIT Health about the health tech revolution in Europe and the Rest of the World. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/eit-health-and-the-international-514 Youtube: https://youtu.be/OnQrvbgcO8Y Kurt Höller: https://www.linkedin.com/in/hoeller/ Joy Cürten: htt…
 
Here is my conversation with Sebastien Groyer, Entrepreneur and Venture Capitalist Episode Links: Article to the Episode: https://lsg2g.substack.com/p/7-tales-from-20-years-of-deep-tech-42f Youtube: https://youtu.be/Ni3mEDM7-_c Sebastien Groyer: https://www.linkedin.com/in/sebastien-groyer-2438548/ Podcast Links: Podcast Website: https://www.lifesc…
 
Here is my conversation with Wolfgang Kienreich, CBO of Know-Center. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/46-an-introduction-to-know-center Youtube: https://youtu.be/eTU5zROX5E4 Wolfgang Kienreich: https://www.linkedin.com/in/wolfgang-kienreich-8350b899/ Know Center: https://www.linkedin.com/company/know-center/ Podca…
 
Here is my conversation with Jama Nateqi, CEO of Symptoma. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/45-hidden-secrets-to-successful-entrepreneurship Youtube: https://youtu.be/VOBc7pfqWOI Jama Nateqi: https://www.linkedin.com/in/jama-nateqi/ Symptoma: https://www.linkedin.com/company/symptoma/ Podcast Links: Podcast Websit…
 
Here is the conversation with Tero Weckroth, Business Angel and Investment Expert from Finland about Public and Private Investments. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/44-private-and-public-investments Video to the Episode: https://youtu.be/7WDHWOyaPQQ Tero Weckroth: https://www.linkedin.com/in/tero-weckroth-5b927/ …
 
Thomas Moser and Tilmann Buerckstuemmer lead the Austrian Life Science Company Aelian Biotechnology. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/gene-editing-the-next-game-changing-d3f Video to the Episode: https://youtu.be/3bf7ChYUHLE Aelian Biotechnology: https://aelian.bio/ Thomas Moser: https://www.linkedin.com/in/thomas…
 
Have you ever wondered what role the small country Austria - located in the center of Europe - plays in Life Science? Then listen to the managing directors of LISAvienna, Johannes Sarx, and Philipp Hainzl. LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Fed…
 
This episode will discuss what it takes to build companies that develop novel therapies, vaccines, and diagnostics in the pharma industry. Since the pandemic, everybody has become familiar with the critical elements of pharma product development. But let’s take a closer look into the value chain of the industry. What does it take to pick up a techn…
 
In history, most of the time, humans needed to provide everything they needed to make a living for themselves. Trading goods were part of life but didn’t take up most of the world’s population’s time. Industrialization changed the job profiles, the needs of workers, and the availability of goods. In this century, many people in the western world ha…
 
This podcast episode will discuss the EU’s next framework program for research and innovation, Horizon Europe, and the exciting opportunities this program offers businesses, scientists, and investors. With the launch of the Horizon Europe program just weeks away, we will share insight into the program's novelties, where to start, and tips on how to…
 
Loading …

Quick Reference Guide

Copyright 2022 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login